Pure Global AI
Manufacturer profile

MEDION GRIFOLS DIAGNOSTICS AG

BrazilSwitzerland41 ANVISA registrations12 unique technical categoriesApr 27, 2015 – Jun 30, 2025
41
Total products
12
Technical names
Apr 2015
Earliest registration
Jun 2025
Latest registration
Regulatory footprint
Search MEDION GRIFOLS DIAGNOSTICS AG across other regulatory registries
Recent registrations
Latest 5 products registered by this manufacturer
Most popular products
Products with most registrations
Top registration holders
Companies holding product registrations for this manufacturer
Top competitors
Companies with the most overlapping products (same technical names)
FRESENIUS HEMOCARE BRASIL LTDA.
Brazil
7 registrations7 shared products
Shared products
ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - LECTINS, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
DIAGNOSTIC GRIFOLS, S.A.
Spain
27 registrations6 shared products
Shared products
ANTI-HUMAN GLOBULIN (COOMBS), IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - RARE SERA FOR COLUMN TECHNOLOGY, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
DIAMED GMBH
Switzerland
17 registrations6 shared products
Shared products
ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - RARE SERA FOR COLUMN TECHNOLOGY, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - HUMAN ORIGIN, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
ORTHO CLINICAL DIAGNOSTICS
United Kingdom
12 registrations6 shared products
Shared products
ANTI-HUMAN GLOBULIN (COOMBS), IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - RARE SERA FOR COLUMN TECHNOLOGY, IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
BIO-RAD LABORATORIOS BRASIL LTDA.
Brazil
12 registrations5 shared products
Shared products
ANTI-HUMAN GLOBULIN (COOMBS), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS IV, IMMUNOHEMATOLOGY - ABO - HUMAN ORIGIN, IMMUNOHEMATOLOGY - ABO - MONOCLONAL ORIGIN, IMMUNOHEMATOLOGY - RH-HR, KELL, KIDD, DUFFY - MONOCLONAL ORIGIN
About this profile

Explore comprehensive manufacturer profile for MEDION GRIFOLS DIAGNOSTICS AG based in Switzerland through Pure Global AI's free Brazil medical device database. This manufacturer has 41 products registered with ANVISA across 12 unique technical categories. Their regulatory history spans from Apr 27, 2015 to Jun 30, 2025.

This page provides detailed insights including 5 recent product registrations including IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY, 5 most popular products with IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS having 10 registrations, 1 registration holders including GRIFOLS BRASIL LTDA, and 5 key competitors with FRESENIUS HEMOCARE BRASIL LTDA. sharing 7 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.